The Background 2-Deoxy-2-[18F]fluoro-d-glucose positron emission tomography (FDG-PET) is a commonly used method to detect regional reductions in brain glucose uptake typically observed in patients with Alzheimer’s disease (AD) and other…
read moreThe Background Cannabidiol was used increasingly over the last 5 years in the therapy of epilepsy and has shown to be effective in reducing seizures in patients with Dravet syndrome,…
read moreIn a guest post on “The MS Blog,” Dr Oliver Findling summarised a recent study on which he was the principal investigator: Humoral Immune Response after the Third SARS-CoV-2 mRNA…
read moreWomen have a unique experience when it comes to stroke. Several differences between the sexes exist in stroke; in the epidemiology of the disease, clinical presentation, medical care and patient…
read moreOver millennia, humans have tried to unveil the mechanisms behind epileptic seizure cyclicity.1 Despite patients with epilepsy often experiencing seizures at consistent times of the day, week, month, or year,…
read moreThe Background The acute clinical manifestations of coronavirus disease 2019 (COVID-19) have been well established. Looking beyond this acute setting, reports have suggested that some people with COVID-19 may experience…
read moreDuring the coronavirus disease 2019 (COVID-19) pandemic, vaccines have been at the forefront of the public consciousness. This is especially true for individuals with multiple sclerosis (MS), as some may…
read more